Serum and tissue expression of neuropilin 1 in precancerous and malignant vocal fold lesions
- PMID: 33002021
- PMCID: PMC7529309
- DOI: 10.1371/journal.pone.0239550
Serum and tissue expression of neuropilin 1 in precancerous and malignant vocal fold lesions
Abstract
Objectives: The study was designed to evaluate the tissue expression of NRP-1 and serum level of sNRP-1 in the same patients with intraepithelial laryngeal lesions or early staged laryngeal cancer to identify the clinical significance of these biomarkers in the diagnosis of laryngeal lesions.
Material and methods: A prospective analysis of tissue was performed on specimens and blood samples from 49 patients, who were admitted for surgical resection due to suspicious vocal fold lesions and were diagnosed as non-dysplasia, low-grade dysplasia, high-grade dysplasia and invasive cancers.
Results: ELISA was conducted on 48 blood samples. The minimum level of sNRP-1 was 0.15 ng/ml and maximum- 37.71 ng/ml. The Kruskal-Wallis one-way analysis of variance revealed no differences in sNRP-1 levels between different histopathological stages of vocal fold lesions (p = 0.234). IHC was conducted in 49 tissue samples. The evaluated mean scores of NRP-1 tissue expression were compared to histopathological stage of the lesion. The Kruskal-Wallis one-way analysis of variance revealed no differences in NRP-1 tissue expression between different histopathological stages of vocal fold lesions (p = 0.536). The correlation of tissue NRP-1 expression and serum levels of NRP-1 within analyzed group was insignificant. The Spearman's rank correlation coefficient was 0.076 (p = 0.606).
Conclusions: The NRP-1 tissue expression and serum levels are unlikely to be a prognostic factor for identification of laryngeal dysplasia or early stage laryngeal cancer. Further studies investigating biomolecules involved in laryngeal carcinogenesis are necessary.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract.Am J Surg Pathol. 2004 Mar;28(3):347-56. doi: 10.1097/00000478-200403000-00007. Am J Surg Pathol. 2004. PMID: 15104297
-
Serum expression of Vascular Endothelial-Cadherin, CD44, Human High mobility group B1, Kallikrein 6 proteins in different stages of laryngeal intraepithelial lesions and early glottis cancer.PeerJ. 2022 Apr 19;10:e13104. doi: 10.7717/peerj.13104. eCollection 2022. PeerJ. 2022. PMID: 35462765 Free PMC article.
-
[Expression of neuropilin-1 in human laryngeal carcinoma and cell lines].Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 Jul;20(14):634-5. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006. PMID: 17017185 Chinese.
-
Institutional and comprehensive review of laryngeal leukoplakia.Ann Otol Rhinol Laryngol. 2008 Jan;117(1):74-9. doi: 10.1177/000348940811700114. Ann Otol Rhinol Laryngol. 2008. PMID: 18254375 Review.
-
Biomarkers in laryngeal dysplasia: a systematic review.Head Neck. 2011 Aug;33(8):1170-6. doi: 10.1002/hed.21592. Epub 2010 Nov 17. Head Neck. 2011. PMID: 21755560 Review.
Cited by
-
New Biosensor for Determination of Neuropilin-1 with Detection by Surface Plasmon Resonance Imaging.Sensors (Basel). 2023 Apr 19;23(8):4118. doi: 10.3390/s23084118. Sensors (Basel). 2023. PMID: 37112459 Free PMC article.
-
Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis.Front Oncol. 2022 Oct 21;12:974885. doi: 10.3389/fonc.2022.974885. eCollection 2022. Front Oncol. 2022. PMID: 36338759 Free PMC article.
-
miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.Int J Mol Sci. 2021 Mar 31;22(7):3640. doi: 10.3390/ijms22073640. Int J Mol Sci. 2021. PMID: 33807389 Free PMC article. Review.
References
-
- Global Cancer observatory. Cancer Today [citated 8 May 2019] In: International Agency for Research on Cancer, World Health Organization. Available from: https://gco.iarc.fr/tomorrow/graphic-isotype?type=0&population=900&mode=...
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
